Welcome to the Department of 

Pathology, Microbiology & Immunology at Vanderbilt


These are exciting times for Vanderbilt and for this department. I am incredibly enthusiastic about what is happening here. The energy and momentum are palpable. The new Department of Pathology, Microbiology and Immunology was recently created by the merger of the former Department of Pathology with the former Department of Microbiology and Immunology.  Our collaborative efforts in personalized medicine in cancer, pharmacogenomics and the creation of Diagnostic Management Teams are at the “leading edge” of a revolution in the practice of pathology. The department lives and breathes our mantra that we are a “laboratory of the whole” for defining the future of pathology.


The Department of Pathology, Microbiology and Immunology at Vanderbilt has a long and rich history of excellence in teaching, clinical service, and research. We are highly regarded for our medical school teaching. Our residents have ample opportunities to develop their teaching skills in the medical school, the medical technology program, and the Belmont University physical therapy program. Opportunities abound for upper level students to participate in the diagnostic and investigative activities of this department. Our Ph.D. programs in Cellular and Molecular Pathology and Microbiology and Immunology are thriving.


Our residency (AP/CP, AP and CP) and fellowship programs (anatomic pathology, hematopathology, renal pathology, GI pathology, neuropathology, clinical chemistry, molecular genetic pathology, molecular medical genetics, clinical microbiology, and cytopathology) have well-deserved national reputations for training superb diagnosticians who are in great demand for positions in both academia and private practice. Our investigators at the graduate student, research fellow, and faculty level are fully engaged in state-of-the-art research using all the tools of modern biological science to push forward the frontiers of pathobiology as they unravel the mysteries of normal biology and disease at the cellular and molecular levels.  A physician-scientist track is available in our residency program for well-prepared and highly motivated individuals.


Renovation of the space and facilities we occupy continues as we develop new offices and laboratories for our department.  Many faculty members moved into newly renovated office, clinical laboratory, and research laboratory space.  Renovation of the clinical laboratories at the Nashville/Middle Tennessee Veterans Administration Hospital on our campus is now complete. We have moved into new transfusion medicine space and opened a new state-of–the-art cytogenetics laboratory. The renovation and expansion of the surgical pathology suite is completed.  Hematopathology also occupies newly renovated state-of-the-art space. 


The next few years will bring continued growth and expansion of our existing residency and fellowship training programs, the development of new ones, and the establishment of new graduate and medical student educational programs all with the intent of preparing our trainees to be leaders well into the 21st century. Similarly, our investigative programs, especially those in the areas of host-pathogen interaction, vascular biology and cancer biology, will undergo marked expansion. We are committed to taking a leadership role in both basic and translational research in these ``areas of focus.'' During this time of rapid growth we remain committed to the foundations of excellence upon which this department rests. 


We hope that from our web site you gain an appreciation for our department and programs and that you can attain a glimpse of the exciting future that we share. We welcome your inquiries and/or your application to join us.


Samuel A. Santoro, M.D., Ph.D.  

Dorothy B. and Theodore R. Austin Professor and Chair of Pathology, Microbiology & Immunology
Professor of Biochemistry

Return to  Top